Clinical effects of Yiqi-Yangyin-Huoxue granules in the management of type 2 diabetes mellitus and early vascular aging: a randomized, double-blind, placebo-controlled trial protocol - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Efficacy of Yiqi-Yangyin-Huoxue Granules in Treating Type 2 Diabetes Mellitus and Mitigating Early Vascular Aging: A Protocol for a Randomized, Double-Blind, Placebo-Controlled Study

  • By

  • Jinyi Fu

  • Yifei Qi

  • Jingyi Zhan

  • Linjing Su

  • Yucong Gao

  • Qingbing Zhou

  • Ying Zhang

  • June 3, 2026

Share

Original Source(s)

Clinical effects of Yiqi-Yangyin-Huoxue granules in the management of type 2 diabetes mellitus and early vascular aging: a randomized, double-blind, placebo-controlled trial protocol

  • by Jinyi Fu, Yifei Qi, Jingyi Zhan, Linjing Su, Yucong Gao, Qingbing Zhou, Ying Zhang

  • June 3, 2026

Related Content

National Cancer Institute–Supported Obesity and Cancer Research, 2015-2022

HHS Proposes Mandatory GRAS Notices

Manufacturers would be required to notify the FDA of GRAS determinations under a proposed rule, while HHS and USDA also submitted the first proposed federal definition of ultra-processed foods for final review.

Correction: Review and analysis of clinical trials of selective RET inhibitors for the treatment of thyroid cancer